You appear to be remarkably incapable of or resistant to making any sort of distinction between companies. If you would take a look at the basic fundamentals of what KBLB is and what it's doing you would see a huge difference between it and the overwhelming majority of other penny stocks:
A market ready product already (Monster Silk).
A company right now testing another KBLB product for suitability for inclusion in its product line.
Several additional products under development with strong evidence of progress (The Gen2 worms being genticaly modified right now with zinc fingers (we could get news on that literally at any moment now).
Then there are the Gen3 products and the platform worm.
KBLB has made a major deal with SIAL, one of the largest and most respected companies in biotechnogy and most of what SIAL is receiving is in the form of royalties (the $70,000 fee is peanuts compared to the potential royalties) so SIAL most definately has a lot of "skin in the game". Not only that but SIAL is highlighting KBLB as the "poster child" for its new custom zinc finger service.
Yet you apparently see no difference between KBLB and other penny stocks. If you want to just trade and consider all stocks equal, that's your business. But it is highly unrealistic to expect all others to take the same approach.
Market Data 
Markets 
AI
